1. GUIDELINES FOR VAGINAL BIRTH AFTER PREVIOUS CAESAREAN BIRTH Dr.Ashraf Fouda Egypt - Damietta General Hospital E. mail : ashraffoda@hotmail.com

2. S.O.G.C. (Society of Obstetricians & Gynecologists of Canada) CLINICAL PRACTICE GUIDELINES This document with articles published from January 1995 to February 2004, obtained by searching the MEDLINE database using the key words “ vaginal birth after C.S. ” SOURCE: July 2004

4. BACKGROUND The most frequent indications for C.S are previous C.S., dystocia, malpresentation, and non-reassuring fetal status. The rate of birth by C.S. and the rate of VBAC tend to be inversely related.

5. Schell first reported VBAC in 1923, describing the successful vaginal delivery of infants in mothers with previous Caesarean deliveries. BACKGROUND

6. A trial of labour after C.S. should be considered in women who present for prenatal care with a history of previous C.S. BACKGROUND

7. In certain situations, TOL after C.S. will be contraindicated and a repeat C.S. will advised, But in most cases, successful vaginal birth can be achieved safely for both mother and infant. BACKGROUND

8. Women and their health-care providers will need to discuss the risks and benefits of VBAC when planning the birth. BACKGROUND

9. The data obtained is limited by 3 important factors: 1. 1. First, there are no randomized trials of TOL versus elective repeat C.S. (ERCS); 2. 2. Second, adverse maternal or perinatal outcomes are rare and large study populations are necessary to observe a significant difference in maternal and perinatal outcomes; and, 3. 3. Finally, the woman’s choice to attempt a TOL after C.S. is heavily influenced by her health-care provider and local resources, often leading to selection bias in published reports. BACKGROUND

10. TRIAL OF LABOUR VERSUS ELECTIVE REPEAT CAESAREAN SECTION The success rate of trial of labour after Caesarean ranges between 50% and 85%. In a study examining 1776 women undergoing TOL after Caesarean, the overall success rate was 74%.

11. Predictors of successful VBAC include nonrecurring indication for Caesarean birth, such as: 1. 1. Malpresentation, 2. 2. Gestational hypertension and a 3. 3. Previous vaginal delivery where success rates are as high as 82%. TRIAL OF LABOUR VERSUS ELECTIVE REPEAT CAESAREAN SECTION

12. When the previous C.S. was for: 1. 1. Dystocia, 2. 2. Failure to progress, or 3. 3. Cephalopelvic disproportion, Some studies found the rates of successful VBAC comparable, while others reported or lower-than- expected rates. TRIAL OF LABOUR VERSUS ELECTIVE REPEAT CAESAREAN SECTION

13. In 1996, McMahon et al. published a report of maternal morbidity in TOL compared to ERCS from 1986 to 1992. In an examination of 3249 women undergoing TOL and 2889 women who delivered by ERCS, the risk of major complications (hysterectomy, uterine rupture, and operative injury) was almost doubled in the TOL group TRIAL OF LABOUR VERSUS ELECTIVE REPEAT CAESAREAN SECTION

14. Complications like puerperal fever, transfusion and abdominal wound infection were comparable. When comparing those who had a successful TOL to those who required a repeat Caesarean section after failed TOL, the risks were greater of operative injury and fever in the failed TOL group. TRIAL OF LABOUR VERSUS ELECTIVE REPEAT CAESAREAN SECTION

15. In 1999, Rageth et al. reviewed 17 613 TOL and 11 433 ERCS deliveries. The rates of hysterectomy,febrile morbidity and thromboembolic complications were less in the TOL group than in the ERCS group. There is less blood loss with a successful VBAC and a shorter hospital stay with more rapid recovery and return to full activity. TRIAL OF LABOUR VERSUS ELECTIVE REPEAT CAESAREAN SECTION

16. Rosen et al. also reported that the risk of febrile morbidity is lower in women who attempt a TOL after Caesarean and is lowest in those who succeed,compared to ERCS, But is increased in those who attempt a TOL and ultimately deliver by Caesarean section. TRIAL OF LABOUR VERSUS ELECTIVE REPEAT CAESAREAN SECTION

17. An examination of 16 938 women who had undergone a Caesarean delivery found that previous C.S. is associated with an increased risk of: 1. 1. Ectopic pregnancy, 2. 2. Placenta previa, and 3. 3. Abruptio placenta TRIAL OF LABOUR VERSUS ELECTIVE REPEAT CAESAREAN SECTION

18. A repeat Caesarean section has been associated with an increased risk of : 1. 1. Placenta previa and 2. 2. Placenta accreta in subsequent pregnancies. TRIAL OF LABOUR VERSUS ELECTIVE REPEAT CAESAREAN SECTION

19. A meta-analysis published in 2000 demonstrated that the overall risk of perinatal death is increased in those attempting a TOL. TRIAL OF LABOUR VERSUS ELECTIVE REPEAT CAESAREAN SECTION

20. The risks of perinatal mortality and severe morbidity are directly related to uterine rupture. If uterine rupture occurs, the risk of perinatal mortality and severe morbidity are increased. TRIAL OF LABOUR VERSUS ELECTIVE REPEAT CAESAREAN SECTION

21. The risk of suspected neonatal sepsis is greater in those attempting a TOL but appears to be confined to the group of TOL who fail and require a repeat Caesarean section. TRIAL OF LABOUR VERSUS ELECTIVE REPEAT CAESAREAN SECTION

22. If an ERCS is chosen, the risk of respiratory problems in the newborn is increased compared to those who have a successful VBAC. TRIAL OF LABOUR VERSUS ELECTIVE REPEAT CAESAREAN SECTION

23. CONTRAINDICATIONS TO VAGINAL BIRTH AFTER CAESAREAN SECTION 1. Previous classical or inverted “T” uterine scar. 2. Previous hysterotomy or myomectomy entering the uterine cavity. 3. Previous uterine rupture. 4. The presence of a contraindication to labour, such as placenta previa, malpresentation. 5. The woman declines a TOL after Caesarean and requests ERCS.

24. PLANNING A TRIAL OF LABOUR AFTER CAESAREAN SECTION The woman and her health- care provider must decide together whether an appropriate situation exists for considering a TOL after Caesarean.

25. DOCUMENTATION OF PREVIOUS UTERINE INCISION Documentation of the location and type of uterine incision used during the previous C.S. is ideal.

26. In most cases, this information can be obtained by reviewing the operative record from the previous surgery. Other information in this record, such as the indication for the Caesarean section and the opinion of the previous surgeon, may be helpful in counselling as well. DOCUMENTATION OF PREVIOUS UTERINE INCISION

27. The fact that the record has been reviewed and that no contraindications to a TOL after Caesarean are present should be documented clearly on the prenatal record. If the record is not available, the scar is considered “ unknown. ” DOCUMENTATION OF PREVIOUS UTERINE INCISION

28. FACILITIES AND RESOURCES A trial of labour after Caesarean is always associated with a risk of uterine rupture, however small. For this reason, a TOL after Caesarean should only be considered in a hospital where provisions for performing an immediate Caesarean section are available.

29. Facilities providing VBAC should have a policy in place to manage such ladies so that all resources are mobilized promptly if an intrapartum emergency occurs. FACILITIES AND RESOURCES

30. The availability and time required for obstetric, anaesthesia, and pediatric services to attend such an emergency should be fully discussed with the woman. FACILITIES AND RESOURCES

31. Women who live in areas where local hospitals cannot offer immediate C.S. should be offered the opportunity for transfer to a facility where this service is available, in order to permit a TOL after Caesarean. FACILITIES AND RESOURCES

32. The members of the team who could be called urgently in the case of an intrapartum complication (anaesthesia, pediatric, and obstetric services) should be notified that the woman is in hospital and in labour and their availability confirmed. FACILITIES AND RESOURCES

33. MATERNAL MONITORING The woman planning a TOL after Caesarean should have appropriate monitoring in labour. Progress of labour should be assessed frequently as there is some evidence that prolonged labour is associated with an increased risk of failure and uterine rupture. Epidural analgesia is not contraindicated.

34. FETAL MONITORING Continuous electronic fetal monitoring in labour is recommended for all women attempting a TOL after Caesarean. The most reliable first sign of uterine rupture is a non-reassuring fetal heart tracing. This may be sudden in onset and may not be related to contractions.

35. POSTPARTUM EVALUATION Routine digital exploration of the Caesarean section scar postpartum is not necessary, except when signs or symptoms suggest uterine rupture.

36. UTERINE RUPTURE Defined as complete separation of the myometrium with or without extrusion of the fetal parts into the maternal peritoneal cavity requiring emergency Caesarean delivery or postpartum laparotomy.

37. It is an uncommon complication of VBAC, but is associated with significant maternal and perinatal morbidity and mortality. UTERINE RUPTURE

38. The most common sign or symptom of uterine rupture is non-reassuring fetal heart rate monitoring. UTERINE RUPTURE

39. Other clinical signs include : 1. 1. Cessation of contractions, 2. 2. Loss of the presenting part on vaginal examination, 3. 3. Abdominal pain, 4. 4. Vaginal bleeding, 5. 5. Hematuria, or 6. 6. Maternal cardiovascular instability. UTERINE RUPTURE

40. The type and location of the previous uterine incision helps to determine the risk of uterine rupture. UTERINE RUPTURE

41. 1. 1. 0.2% to 1.5% in a woman who attempts labour after a transverse lower-uterine- segment incision and 2. 2. 1% to 1.6% after a vertical incision in the lower uterine segment. 3. 3. 4% to 9% with a classical or “ T ” incision; and for this reason, a TOL after Caesarean is contraindicated in these situations. UTERINE RUPTURE INCIDENCE

42. Shimonovitz et al. found the risk of uterine rupture after 0, 1, 2, and 3 VBAC deliveries to be 1.6%, 0.3%, 0.2%, and 0.35%, respectively, Indicating that the risk of uterine rupture decreases after the first successful VBAC. UTERINE RUPTURE

43. The presence of placental or fetal part extrusion at laparotomy was associated with severe metabolic acidosis. Even in situations where very rapid decision to delivery times were recorded, some cases of perinatal acidosis could not be avoided. UTERINE RUPTURE

44. The relative risk of: 1. 1. uterine rupture, 2. 2. maternal morbidity, and 3. 3. perinatal mortality or severe morbidity is increased in those undergoing a TOL after Caesarean compared to ERCS, but that the absolute risk remains very low. UTERINE RUPTURE

45. The treatment of suspected uterine rupture is immediate laparotomy after maternal stabilization and anaesthesia. Once the fetus is delivered, maternal hemorrhage must be arrested, and if the uterus cannot be salvaged, hysterectomy may be required. UTERINE RUPTURE

46. In 1996, Rozenberg et al. examined ultrasonographic measurement of the lower uterine segment’s myometrial thickness 36 to 38 weeks’ gestation as a predictor of uterine rupture. UTERINE RUPTURE

47. If the lower segment thickness was less than 3.5 mm, the risk of uterine rupture or dehiscence was 11.8%; and the measurement was greater than 3.5 mm, the risk of uterine rupture was minimal. UTERINE RUPTURE

48. In a follow-up open study, Rozenberg et al. found that the use of the lower-uterine- segment measurement helped clinicians select women for a TOL after Caesarean. UTERINE RUPTURE

49. OXYTOCICS AND TRIAL OF LABOUR AFTER CAESAREAN SECTION

50. In 1987, Flamm et al. performed a multicentre examination of 485 women who received oxytocin to augment their spontaneous labour in a planned TOL after Caesarean. No increase in the risk of uterine rupture, maternal morbidity, or perinatal morbidity or mortality was detected. AUGMENTATION

51. Zelop et al. supported the same conclusion about the risk of uterine rupture with augmentation in a 1999 study. AUGMENTATION

52. Goetzl et al. examined the relationship between the dose of oxytocin used and the risk of uterine rupture in women undergoing a TOL after Caesarean. No significant association was detected between exposure to oxytocin and the risk of uterine rupture. AUGMENTATION

53. Careful surveillance of the woman for progress of labour is required, especially when the diagnosis of dystocia is being considered. There are insufficient studies examining the use of other agents to augment labour, such as prostaglandins, and their safety in a TOL after Caesarean. AUGMENTATION

54. INDUCTION In 2000, Ravasia et al. reviewed the risk of uterine rupture in women undergoing an induction TOL after Caesarean. In 575 women with a previous Caesarean section, labour was induced with: 1. 1. Prostaglandin E2 gel, 2. 2. Intracervical foley catheter, or 3. 3. Amniotomy and/or oxytocin. Outcomes were compared to those women undergoing a TOL with spontaneous labour.

55. The risk of uterine rupture was not increased in those who underwent either amniotomy/oxytocin or foley catheter induction, but was significantly increased in those who underwent a prostaglandin E2 induction. INDUCTION

56. In 2000, Sanchez-Ramos et al. performed a meta-analysis looking at the efficacy and safety of prostaglandin E2 for cervical ripening in women with a previous C.S. and found it to be effective and not associated with an increased risk of uterine rupture compared to spontaneous labour. INDUCTION

57. In 2003, Delaney and Young reported the examination of 3746 women with a prior Caesarean delivery who underwent either induced or spontaneous labour. They found that induced labour was associated with a greater risk of : 1. 1. Early postpartum hemorrhage (7.3% vs. 5.0%), 2. 2. Caesarean delivery (37.5% vs. 24.2%), and 3. 3. Admission to a neonatal intensive care unit (13.3% vs. 9.4%). INDUCTION

58. There was a trend towards a higher rate of uterine rupture, but this was not statistically significant (0.7% vs. 0.3%). INDUCTION

59. In another retrospective study of 560 women, the rate of uterine rupture in women whose labour was induced with : Oxytocin was 2%, with Prostaglandin was 2.9%, and With both was 4.5%. INDUCTION

60. Up to 2001, there was conflicting data on the risk of induction of labour with prostaglandin E2. Several other smaller studies reported that it appeared to be safe, effective, and not associated with an increased risk of uterine rupture. INDUCTION

61. In the largest study published to date, conducted by Lydon- Rochelle et al., the incidence of uterine rupture was reviewed retrospectively in 20 095 women with a previous C.S. and reported as follows: 1. 1. Elective repeat C.S. (no labour) 0.16%; 2. 2. Spontaneous labour 0.52% ; 3. 3. Labour induced without prostaglandin 0.77% ; and 4. 4. Labour induced with prostaglandin 2.45%. INDUCTION

62. The possibility that the use of oxytocin and/or prostaglandin for induction of labour in women considering a TOL after Caesarean may be associated with an increased risk of uterine rupture and its sequelae must be discussed with the patient. The absolute risks of uterine rupture are low, but the relative risks (especially with the use of prostaglandin E2 compared to spontaneous labour) are greater. INDUCTION

63. MISOPROSTOL Misoprostol has been proposed as an effective and economical agent for cervical ripening and induction. In 1998, Sciscione et al. reported a case of uterine rupture in a woman with 2 previous Caesarean sections after misoprostol was administered as a cervical ripening agent. A number of small series reported a risk of uterine rupture from 0% to 11.7% with misoprostol in women undergoing a TOL after Caesarean.

64. Blanchette et al. compared prostaglandin E2 to misoprostol in women undergoing induction TOL after Caesarean and found them to be equally effective, But misoprostol was associated with a higher incidence of uterine rupture (18.8% compared to no ruptures in the prostaglandin E2 group). The numbers in all of these studies are small and it is difficult to draw meaningful conclusions. MISOPROSTOL

65. Until further randomized studies are completed, misoprostol should be discouraged as a method of induction or cervical ripening in women with previous Caesarean delivery. MISOPROSTOL

66. CERVICAL PREPARATION In situations where delivery is indicated and the cervix is unfavourable, a TOL after Caesarean can be considered. In a cohort study published in 2002, Ben-Aroya et al. compared women undergoing a trial of labour after Caesarean section in 3 situations: 1. 1. Spontaneous labour (n=1432), 2. 2. Prostaglandin cervical ripening (n=55), and 3. 3. Cervical ripening by foley catheter (n=161).

67. There was a significantly higher rate of dystocia (30.4% vs. 11.6%) and repeat Caesarean section in the second stage (49.1% vs. 35.2%) in the foley catheter group compared to the control group. There was no difference in the rate of uterine rupture, fetal distress, or Apgar scores. CERVICAL PREPARATION

68. In a Canadian study published in 2004, Bujold et al. compared the rate of uterine rupture in 1807 women who presented in spontaneous labour, 417 induced with amniotomy with or without oxytocin, and 255 induced with transcervical foley catheter. CERVICAL PREPARATION

69. The rate of successful vaginal birth was : 1. 1. 78% in the spontaneous group, 2. 2. 77.9% in the amniotomy group, and 3. 3. 55.7% in the transcervical foley group. However, the rates of uterine rupture did not differ significantly: 1.1%, 1.2%, and 1.6%, respectively. CERVICAL PREPARATION

70. These data support the use of the foley catheter for cervical ripening of an unfavourable cervix in women undergoing a TOL after Caesarean. CERVICAL PREPARATION

71. SPECIAL CIRCUMSTANCES

72. MORE THAN ONE PREVIOUS LOW TRANSVERSE C.S. Several authors have assessed the rate of successful VBAC and risk of uterine rupture in women with more than one previous low transverse Caesarean section. All indicated success rates between 62% and 89%, and uterine rupture rates between 0% and 3.7%.

73. Unfortunately, the use of prostaglandins or oxytocin for induction or augmentation was not considered. Caughey et al. reported a uterine rupture rate of 3.7% versus 0.8% in a retrospective review of 134 women undergoing labour after 2 previous Caesarean sections. MORE THAN ONE PREVIOUS LOW TRANSVERSE C.S.

74. In the largest study, Miller et al. demonstrated : A VBAC success rate of 75.3% in 1827 women with 2 or more previous low transverse Caesarean sections with A uterine rupture rate of 1.7% vs. 0.6% in the ERCS group. MORE THAN ONE PREVIOUS LOW TRANSVERSE CAESAREAN SECTION

75. MULTIPLE PREGNANCY Seven studies have examined a total of 233 women attempting VBAC in multiple pregnancy. All support a trial of VBAC in multiple pregnancy as being safe and effective, With success rates of 69% to 84%, and without increased maternal or fetal morbidity or mortality.

76. In one study, uterine dehiscence was noted in 1 woman on manual exploration after successful vaginal delivery of both twins, and no treatment was required. Each of these studies examined a small number of women, however; and greater numbers would be required to detect rare outcomes such as uterine rupture and maternal and perinatal mortality. MULTIPLE PREGNANCY

77. BREECH PRESENTATION A large multicentre trial by Hannah et al. demonstrated that a planned Caesarean birth is associated with better perinatal and neonatal outcomes in breech presentation at term. This recommendation has been adopted by the SOGC and would therefore preclude a planned TOL after Caesarean in women presenting with a singleton fetus in breech presentation at term.

78. External cephalic version is not contraindicated in a woman with a previous Caesarean birth. BREECH PRESENTATION

79. DIABETES MELLITUS Coleman et al. examined 156 women with GDM and planned TOL after Caesarean and compared them to non-GDM women attempting TOL after Caesarean. They reported that the success rate for VBAC of 64.1% in women with GDM was lower than the 77.2% of women without GDM. Maternal and fetal morbidities were comparable.

80. A retrospective study of TOL after Caesarean in women with pre- gestational or gestational diabetes found similar results. Based on these studies, diabetes mellitus should not be considered a contraindication to TOL after Caesarean. DIABETES MELLITUS

81. MACROSOMIA In a study examining the outcome of 365 women who underwent a TOL after Caesarean, giving birth to neonates weighing more than 4000 g, Zelop et al. demonstrated a success rate of 60%, with no increase in maternal or fetal morbidity and no increase in the risk of uterine rupture.

82. In 2003, Elkousy et al. reported an examination of 9960 women with a previous C.S. planning a trial of labour further stratified by neonatal birth weights and birth history. His results indicate that the likelihood of successful VBAC decreases with increasing birth weight and is lowest in those who have never had a successful vaginal birth. MACROSOMIA

83. Based on these results, suspected macrosomia is not a contraindication to a TOL after Caesarean, although it may be associated with a lower chance of success. MACROSOMIA

84. INTERDELIVERY INTERVAL Four studies have examined the relationship between the inter-delivery interval and the rate of successful VBAC and uterine rupture.

85. Esposito et al. examined 23 cases of uterine rupture and compared them to 127 controls. There was an increased risk of uterine rupture with a short interpregnancy interval (<6 months between pregnancies; <15 months between deliveries) compared to controls (17.4% vs. 4.7%). INTERDELIVERY INTERVAL

86. Shipp et al. reviewed 311 women who underwent a TOL after Caesarean less than 18 months after their Caesarean section and compared them to 2098 women who underwent a TOL after Caesarean after more than 18 months. The shorter interval was associated with a 3-fold increase in the risk of uterine rupture (2.25% vs. 1.05%). INTERDELIVERY INTERVAL

87. In 2002, Bujold et al. reported an observational study of 1527 women undergoing a planned TOL after Caesarean at different intervals from the index Caesarean delivery. INTERDELIVERY INTERVAL

88. The rates of uterine rupture were as follows: 1. 1. <12 months, 5%; 2. 2. 13 - 24 months, 3%; 3. 3. 25 - 36 months, 1%; and 4. 4. >36 months, 1%. INTERDELIVERY INTERVAL

89. POSTDATISM Three studies have examined postdatism and TOL after Caesarean. Success rates for VBAC after 40 weeks were reported from 65% to 73% and were comparable to success rates for women delivered before 40 weeks.

90. Zelop et al. reported that the risk of uterine rupture in a TOL after Caesarean after 40 weeks was not significantly increased when compared to those who delivered before 40 weeks, whether in spontaneous labour or after induction. POSTDATISM

91. ONE- VERSUS TWO-LAYER CLOSURE OF LOW TRANSVERSE CAESAREAN SECTION In 1992, Hauth et al. published data comparing : 1. 1. Operative time, 2. 2. Endometritis, 3. 3. Transfusion, and 4. 4. Placement of extra hemostatic sutures in women undergoing uterine closure in 1 layer compared to 2 layers.

92. The only significant difference was in operative time: 44 minutes with 1-layer compared to 48 minutes with 2-layer closure. Similar findings were published by Ohel et al. in 1996. The trend shifted in many centres towards single-layer closure. ONE- VERSUS TWO-LAYER CLOSURE OF LOW TRANSVERSE CAESAREAN SECTION

93. In 1997, Chapman et al. published a review of 145 women who underwent a TOL after Caesarean after being randomized to either 1-layer or 2-layer closure in the previous Caesarean section. They reported no significant difference in the outcome of the next pregnancy. ONE- VERSUS TWO-LAYER CLOSURE OF LOW TRANSVERSE CAESAREAN SECTION

94. In a 2002 review of 2142 women who underwent a TOL after Caesarean, Bujold et al. noted that a 1-layer interlocking closure was associated with an increased risk of uterine rupture when compared to a 2-layer closure (3.1% vs. 0.5%). Further study in this area is recommended. ONE- VERSUS TWO-LAYER CLOSURE OF LOW TRANSVERSE CAESAREAN SECTION

95. UNKNOWN SCAR All records available or obtainable describing the woman ’ s previous C.S. should be reviewed. If unavailable, information about the circumstances of the C.S. will help determine the likelihood of a vertical uterine incision. The majority of unknown scars will be lower transverse incisions (92%) and therefore at low risk for uterine rupture.

96. If the history suggests a reasonable likelihood of a classical incision, it would be prudent to recommend a repeat C.S., But in settings where the history indicates a high likelihood of lower transverse uterine incision and the woman wishes to proceed after counselling, a TOL after Caesarean is acceptable. UNKNOWN SCAR

97. OTHER FACTORS Factors such as : 1. 1. Maternal obesity, 2. 2. The presence of postpartum fever after Caesarean section, 3. 3. Type of suture material, 4. 4. M ü llerian duct anomalies, and 5. 5. Maternal age and Their relationship to the risk of uterine rupture have been examined in small studies, but definitive conclusions cannot yet be drawn.

98. Recommendations: Provided there are no contraindications, a woman with one previous transverse L.S.C.S. should be offered a trial of labour after C.S. with appropriate discussion of maternal and perinatal risks and benefits. Provided there are no contraindications, a woman with one previous transverse L.S.C.S. should be offered a trial of labour after C.S. with appropriate discussion of maternal and perinatal risks and benefits. (II-2B)

99. The process of informed consent with appropriate documentation should be an important part of the birth plan in a woman with a previous C.S. The process of informed consent with appropriate documentation should be an important part of the birth plan in a woman with a previous C.S. Recommendations: (II-2B)

100. The intention of a woman undergoing a TOL after C.S. should be clearly stated and documentation of the previous uterine scar should be clearly marked on the prenatal record. The intention of a woman undergoing a TOL after C.S. should be clearly stated and documentation of the previous uterine scar should be clearly marked on the prenatal record. Recommendations: (II-2B)

101. For a safe labour after C.S., the woman should deliver in a hospital where an immediate C.S. is available. For a safe labour after C.S., the woman should deliver in a hospital where an immediate C.S. is available. Recommendations: (II-2A)

102. The woman and her health-care provider must be aware of the hospital resources and the availability of obstetric, anaesthesia, pediatric, and operating-room staff. The woman and her health-care provider must be aware of the hospital resources and the availability of obstetric, anaesthesia, pediatric, and operating-room staff. Recommendations: (II-2A)

103. Each hospital should have a written policy in place regarding the notification and/or consultation for the physicians responsible for a possible immediate C.S. Each hospital should have a written policy in place regarding the notification and/or consultation for the physicians responsible for a possible immediate C.S. Recommendations: (III B)

104. Continuous electronic fetal monitoring of women attempting a TOL after C.S. is recommended. Continuous electronic fetal monitoring of women attempting a TOL after C.S. is recommended. Recommendations: (II-2A)

105. Suspected uterine rupture requires urgent attention and expedited laparotomy in order to attempt to decrease maternal and perinatal morbidity and mortality. Suspected uterine rupture requires urgent attention and expedited laparotomy in order to attempt to decrease maternal and perinatal morbidity and mortality. Recommendations: (II-2A)

106. Oxytocin augmentation is not contraindicated in women undergoing a TOL after C.S. Oxytocin augmentation is not contraindicated in women undergoing a TOL after C.S. Recommendations: (II-2A)

107. Medical induction of labour with oxytocin may be associated with an increased risk of uterine rupture and should be used carefully after appropriate counselling. Medical induction of labour with oxytocin may be associated with an increased risk of uterine rupture and should be used carefully after appropriate counselling. Recommendations: (II-2B)

108. Medical induction of labour with prostaglandin E2 (dinoprostone) is associated with an increased risk of uterine rupture and should not be used except in rare circumstances after appropriate counselling. Medical induction of labour with prostaglandin E2 (dinoprostone) is associated with an increased risk of uterine rupture and should not be used except in rare circumstances after appropriate counselling. Recommendations: (II-2B)

109. Prostaglandin E1 (misoprostol) is associated with a high risk of uterine rupture and should not be used as part of a TOL after C.S. Prostaglandin E1 (misoprostol) is associated with a high risk of uterine rupture and should not be used as part of a TOL after C.S. Recommendations: (II-2A)

110. A foley ’ s catheter may be used safely to ripen the cervix in a woman planning a TOL after C.S. A foley ’ s catheter may be used safely to ripen the cervix in a woman planning a TOL after C.S. Recommendations: (II-2A)

111. The available data suggest that a trial of labour in women with more than one previous C.S. is likely to be successful but is associated with a higher risk of uterine rupture. The available data suggest that a trial of labour in women with more than one previous C.S. is likely to be successful but is associated with a higher risk of uterine rupture. Recommendations: (II-2B)

112. Multiple gestation is not a contraindication to a TOL after Caesarean. Multiple gestation is not a contraindication to a TOL after Caesarean. Recommendations: (II-2B)

113. Diabetes mellitus is not a contraindication to TOL after C.S. Diabetes mellitus is not a contraindication to TOL after C.S. Recommendations: (II-2B)

114. Suspected fetal macrosomia is not a contraindication to a TOL after Caesarean. Suspected fetal macrosomia is not a contraindication to a TOL after Caesarean. Recommendations: (II-2B)

115. Women delivering within 18 to 24 months of a C.S. should be counseled about an increased risk of uterine rupture in labour. Women delivering within 18 to 24 months of a C.S. should be counseled about an increased risk of uterine rupture in labour. Recommendations: (II-2B)

116. Postdatism is not a contraindication to a TOL after Caesarean. Postdatism is not a contraindication to a TOL after Caesarean. Recommendations: (II-2B)

117. Every effort should be made to obtain the previous Caesarean section operative report to determine the type of uterine incision used. Every effort should be made to obtain the previous Caesarean section operative report to determine the type of uterine incision used. Recommendations: (II-2B)

118. In situations where the scar is unknown, information concerning the circumstances of the previous delivery is helpful in determining the likelihood of a low transverse incision. In situations where the scar is unknown, information concerning the circumstances of the previous delivery is helpful in determining the likelihood of a low transverse incision. If the likelihood of a lower transverse incision is high, TOL after Caesarean can be offered. If the likelihood of a lower transverse incision is high, TOL after Caesarean can be offered. Recommendations: (II-2B)